Runners’ Gut Damage Shows Up in Blood, But Symptoms Don’t Follow

Endurance runners routinely damage their gut walls during hard efforts in the heat, yet many never feel a thing. A new integrated analysis published in June 2026 by Hillemacher and colleagues suggests that the biological signals of that damage, measurable in the blood, have surprisingly little power to predict which athletes will actually experience gastrointestinal distress during exercise. The findings complicate a widely held assumption that gut injury and gut symptoms go hand in hand.

Gut Biomarker Elevations Occurred Without Overt Symptoms

The study pooled data from four prior experiments involving 56 non-heat-acclimated endurance runners (39 male, 17 female) who each completed two hours of steady-state treadmill running at 60% VO2max in a 35-degree Celsius environmental chamber. Before each trial, all participants followed a standardized 24-hour low-FODMAP diet to limit food-driven gut irritation. Blood was drawn before and after exercise to measure intestinal fatty acid binding protein (I-FABP, a sensitive marker of enterocyte, or gut-lining cell, damage), bacterial translocation markers (LBP, sCD14, IgM), and a panel of inflammatory cytokines including IL-6, IL-10, IL-1ra, TNF-alpha, IL-1beta, and IL-8.

I-FABP concentrations exceeded the marker's minimum detectable change in most participants, confirming real epithelial injury. Yet the correlation between I-FABP and any reported gastrointestinal symptom was not statistically meaningful in the overall cohort. The same pattern held for the bacterial translocation markers: LBP, sCD14, and IgM each shifted without linking reliably to symptoms. Significant physiological perturbation of the gut, it turns out, can be entirely silent.

Why Exercise GI Distress Affects So Many Endurance Athletes

The pathophysiology of exercise-induced GI symptoms in endurance sport is multifactorial, involving reduced blood flow to the gut (splanchnic hypoperfusion), disrupted motility driven by sympathetic nervous system activation, and inflammatory cascades triggered by bacterial products leaking across a compromised gut wall. Reviews estimate that up to 70% of endurance athletes experience some form of gut trouble during strenuous efforts, and prevalence of exercise-induced GI symptoms reaches 90% or higher in some ultra-endurance events.

Heat stress makes everything worse. It amplifies epithelial damage, accelerates endotoxin translocation, and dramatically boosts the IL-6 response. The current study found that IL-6 did show a moderate positive correlation with one specific symptom: defecation with bloody stools (rs = 0.437, p = 0.003), explaining about 9.4% of the variance in that outcome. That is a meaningful signal, but it still leaves more than 90% of the variance unexplained. The EIGS impact on athlete performance and health can range from a ruined race to a medical emergency, which is precisely why understanding its predictors matters so much.

Inflammatory Cytokines Carry the Strongest, Yet Still Modest, Signals

Among all biomarkers tested, the anti-inflammatory and regulatory cytokines produced the most consistent correlations with symptoms, and even those were modest. IL-10, a counter-regulatory cytokine activated in response to elevated IL-6, showed a moderate positive correlation with upper abdominal pain (rs = 0.401, p = 0.028) and a moderate negative correlation with flatulence (rs = -0.402, p = 0.027). Both IL-1ra and the composite Systemic Inflammatory Response (SIR) Profile independently showed moderate negative correlations with flatulence as well.

The authors interpret the IL-10 and flatulence connection as a possible protective signal: a stronger anti-inflammatory response may be suppressing the motility disturbances and luminal gas that produce bloating and gas-related discomfort. Conversely, the positive link between IL-10 and upper abdominal pain may reflect that the athletes experiencing the most intense inflammatory responses, requiring the strongest counter-response, are also the ones feeling pain.

In sex-stratified sub-analyses (limited by the unequal sample: 17 women versus 39 men), I-FABP showed moderate positive associations with upper bloating and upper abdominal pain in female runners (rs = 0.571 for both). Nausea in women correlated strongly with TNF-alpha (rs = 0.671) and moderately with IL-8 (rs = 0.592). These patterns hint that gut injury may translate into symptoms differently across sexes, but the sample size is too small to draw firm conclusions.

Why a Single Biomarker Cannot Predict Who Will Suffer

The unclear link between intestinal permeability and GI symptoms has been flagged before in the running literature, and this study reinforces it at the multi-biomarker level. No single marker explained more than 14% of the variance in any symptom. That modest explanatory power points to a genuinely multifactorial etiology: gut symptoms during exercise are unlikely to be reducible to one pathway or one blood test.

The study carries meaningful limitations. Integrating data from four independent studies introduced inter-study variability, and ELISA assays were run across different laboratory lots without consistency controls. Several biomarkers, including LBP, TNF-alpha, and IL-1beta, did not surpass their own minimum detectable change thresholds, potentially masking associations. And with only 17 female participants, any sex-specific findings remain preliminary.

Inflammatory Profiling as a Future Screening Tool for Athletes

Despite modest effect sizes, the authors argue that inflammatory cytokine profiling could still serve as a useful screening tool to identify athletes at heightened risk of severe EIGS during exertional heat stress. A cluster of elevated pro-inflammatory and regulatory markers before or during competition might flag individuals who need closer monitoring or targeted nutrition support, even if no individual marker is definitive.

Nutritional strategies for mitigating GI symptoms such as gut-training protocols, carbohydrate intake optimization, and low-FODMAP dietary manipulation already show promise in reducing symptom burden, but they are largely applied reactively after symptoms appear. A biomarker-informed approach could, in principle, allow preventive interventions before an athlete reaches a race. Future studies, the authors suggest, should extend beyond trained runners to include occupational groups such as military personnel and firefighters, as well as untrained individuals, where pathophysiological responses may be larger and symptom associations stronger.

Evidence rating

INVESTIGATIONAL — 76/100

Caveats:

• Pooled metadata from four separate studies with n=56 total; inter-study variability and inconsistent ELISA lot-to-lot controls limit confidence in the findings.
• Individual biomarkers explained at most 13.8% of symptom variance — no single marker reliably predicts gastrointestinal symptoms.
• Observational correlational design; results show association, not causation.
• Biomarkers were measured only at pre- and post-exercise timepoints, missing real-time dynamics during exercise.
• Female participants were underrepresented (n=17 vs. n=39 male), limiting the reliability of sex-stratified findings.
• Funding was not disclosed by the authors.

Pooled cross-sectional analysis integrating data from four independent experimental studies (n=56 endurance-trained runners). The study identifies modest correlations between systemic inflammatory cytokines and specific gastrointestinal symptoms under heat stress, but the observational design precludes causal inference, individual biomarkers explain no more than 13.8% of symptom variance, and findings have not been independently replicated in a prospectively designed cohort.

References

1. Keagan Hillemacher, Charlie Beaconsfield, Samuel Fitzgerald, et al. (2026). The Relationship Between Biomarkers of Exercise-Induced Gastrointestinal Syndrome and Exercise-Associated Gastrointestinal Symptoms. Sports. https://doi.org/10.3390/sports14060248
2. Emanuela Ribichini, Giulia Scalese, Alessandra Cesarini, et al. (2023). Exercise-Induced Gastrointestinal Symptoms in Endurance Sports: A Review of Pathophysiology, Symptoms, and Nutritional Management. Dietetics. https://doi.org/10.3390/dietetics2030021
3. Erick Prado de Oliveira, Roberto Carlos Burini, Asker Jeukendrup (2014). Gastrointestinal Complaints During Exercise: Prevalence, Etiology, and Nutritional Recommendations. Sports Medicine. https://doi.org/10.1007/s40279-014-0153-2
4. Grégoire P. Millet, Antoine Raberin, Bastien Krumm (2025). Comment on: “Sports Dietitians Australia and Ultra Sports Science Foundation Joint Position Statement: A Practitioner Guide to the Prevention and Management of Exercise-Associated Gastrointestinal Perturbations and Symptoms”. Sports Medicine. https://doi.org/10.1007/s40279-025-02274-7
5. Elisa Karhu, Richard A. Forsgård, Lauri Alanko, et al. (2017). Exercise and gastrointestinal symptoms: running-induced changes in intestinal permeability and markers of gastrointestinal function in asymptomatic and symptomatic runners. European Journal of Applied Physiology. https://doi.org/10.1007/s00421-017-3739-1
6. Janez Mlinaric, Nina Mohorko (2025). Nutritional strategies for minimizing gastrointestinal symptoms during endurance exercise: systematic review of the literature. Journal of the International Society of Sports Nutrition. https://doi.org/10.1080/15502783.2025.2529910